|
1
|
Lazzari AA, Dussault PM, Thakore-James M,
Gagnon D, Baker E, Davis SA and Houranieh AM: Prevention of bone
loss and vertebral fractures in patients with chronic epilepsy -
anti-epileptic drug and osteoporosis prevention trial. Epilepsia.
54:1997–2004. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Delger AB, Avakyan GN, Oleinikova OM,
Bogomazova MA, Chromych EA and Lagutin IuV: Effects of tenoten on
anxiety and depression disorders in patients with epilepsy. Bull
Exp Biol Med. 153:704–706. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Jacoby A, Sudell M, Tudur Smith C,
Crossley J, Marson AG and Baker GA; SANAD Study Group:
Quality-of-life outcomes of initiating treatment with standard and
newer antiepileptic drugs in adults with new-onset epilepsy:
Findings from the SANAD trial. Epilepsia. 56:460–472. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Jóźwiak S, Kotulska K, Domańska-Pakieła D,
Lojszczyk B, Syczewska M, Chmielewski D, Dunin-Wąsowicz D, Kmieć T,
Szymkiewicz-Dangel J, Kornacka M, et al: Antiepileptic treatment
before the onset of seizures reduces epilepsy severity and risk of
mental retardation in infants with tuberous sclerosis complex. Eur
J Paediatr Neurol. 15:424–431. 2011. View Article : Google Scholar
|
|
5
|
French JA, Abou-Khalil BW, Leroy RF,
Yacubian EM, Shin P, Hall S, Mansbach H and Nohria V; RESTORE
1/Study 301 Investigators: Randomized, double-blind,
placebo-controlled trial of ezogabine (retigabine) in partial
epilepsy. Neurology. 76:1555–1563. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sharma S, Sankhyan N, Gulati S and
Agarwala A: Use of the modified Atkins diet for treatment of
refractory childhood epilepsy: A randomized controlled trial.
Epilepsia. 54:481–486. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kerr EN and Blackwell MC: Near-transfer
effects following working memory intervention (Cogmed) in children
with symptomatic epilepsy: An open randomized clinical trial.
Epilepsia. 56:1784–1792. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Li MM, Li XM, Zheng XP, Yu JT and Tan L:
MicroRNAs dysregulation in epilepsy. Brain Res. 1584:94–104. 2014.
View Article : Google Scholar
|
|
9
|
Ashhab MU, Omran A, Kong H, Gan N, He F,
Peng J and Yin F: Expressions of tumor necrosis factor alpha and
microRNA-155 in immature rat model of status epilepticus and
children with mesial temporal lobe epilepsy. J Mol Neurosci.
51:950–958. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Li Y, Wang J, Jiang C, Zheng G, Lu X and
Guo H: Association of the genetic polymorphisms in pre-microRNAs
with risk of childhood epilepsy in a Chinese population. Seizure.
40:21–26. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Li MM, Jiang T, Sun Z, Zhang Q, Tan CC, Yu
JT and Tan L: Genome-wide microRNA expression profiles in
hippocampus of rats with chronic temporal lobe epilepsy. Sci Rep.
4:47342014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Henshall DC: MicroRNA and epilepsy:
Profiling, functions and potential clinical applications. Curr Opin
Neurol. 27:199–205. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Xue Y, Xie N, Cao L, Zhao X, Jiang H and
Chi Z: Diazoxide preconditioning against seizure-induced oxidative
injury is via the PI3K/Akt pathway in epileptic rat. Neurosci Lett.
495:130–134. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Xiao Z, Peng J, Yang L, Kong H and Yin F:
Interleukin-1β plays a role in the pathogenesis of mesial temporal
lobe epilepsy through the PI3K/Akt/mTOR signaling pathway in
hippocampal neurons. J Neuroimmunol. 282:110–117. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zheng H, Wang X, Tang Z, Zheng W and Li Z:
The PI3K/Akt and ERK1/2 signaling pathways mediate the
erythropoietin-modulated calcium influx in kainic acid-induced
epilepsy. Neuroreport. 24:335–341. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wong M: mTOR strikes again: mTORC1
activation causes epilepsy independent of overt pathological
changes. Epilepsy Curr. 14:41–43. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Bockaert J and Marin P: mTOR in brain
physiology and pathologies. Physiol Rev. 95:1157–1187. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
19
|
Aalbers MW, Klinkenberg S, Rijkers K,
Verschuure P, Kessels A, Aldenkamp A, Vles J and Majoie M: The
effects of vagus nerve stimulation on pro- and anti-inflammatory
cytokines in children with refractory epilepsy: An exploratory
study. Neuroimmunomodulation. 19:352–358. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Meurer WJ, Silbergleit R, Nicholas KS,
Burke JF and Durkalski V: Accounting for repeat enrollments during
an emergency clinical trial: The Rapid Anticonvulsant Medications
Prior to Arrival Trial (RAMPART). Acad Emerg Med. 22:373–377. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ryvlin P, Gilliam FG, Nguyen DK, Colicchio
G, Iudice A, Tinuper P, Zamponi N, Aguglia U, Wagner L, Minotti L,
et al: The long-term effect of vagus nerve stimulation on quality
of life in patients with pharmacoresistant focal epilepsy: The
PuLsE (Open Prospective Randomized Long-term Effectiveness) trial.
Epilepsia. 55:893–900. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hu K, Xie YY, Zhang C, Ouyang DS, Long HY,
Sun DN, Long LL, Feng L, Li Y and Xiao B: MicroRNA expression
profile of the hippocampus in a rat model of temporal lobe epilepsy
and miR-34a-targeted neuroprotection against hippocampal neurone
cell apoptosis post-status epilepticus. BMC Neurosci. 13:1152012.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zucchini S, Marucci G, Paradiso B, Lanza
G, Roncon P, Cifelli P, Ferracin M, Giulioni M, Michelucci R,
Rubboli G, et al: Identification of miRNAs differentially expressed
in human epilepsy with or without granule cell pathology. PLoS One.
9:e1055212014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Reschke CR and Henshall DC: microRNA and
Epilepsy. Adv Exp Med Biol. 888:41–70. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Manna I, Labate A, Borzì G, Mumoli L,
Cavalli SM, Sturniolo M, Quattrone A and Gambardella A: An SNP site
in primiR-124, a brain expressed miRNA gene, no contribution to
mesial temporal lobe epilepsy in an Italian sample. Neurol Sci.
37:1335–1339. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Tzeng TT, Tsay HJ, Chang L, Hsu CL, Lai
TH, Huang FL and Shiao YJ: Caspase 3 involves in neuroplasticity,
microglial activation and neurogenesis in the mice hippocampus
after intracerebral injection of kainic acid. J Biomed Sci.
20:902013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Aanandhi MV, Bhattacherjee D, Ray A and
George PS: New avenue in the treatment of temporal lobe epilepsy by
classical anti-epileptics: A hypothetical establishment of
executioner Caspase 3 inactivation by molecular modeling. J Adv
Pharm Technol Res. 6:65–74. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Meng XJ, Wang F and Li CK: Resveratrol is
neuroprotective and improves cognition in
pentylenetetrazole-kindling model of epilepsy in rats. Indian J
Pharm Sci. 76:125–131. 2014.PubMed/NCBI
|
|
29
|
Chen X, Bao G, Hua Y, Li Y, Wang Z and
Zhang X: The effects of topiramate on caspase-3 expression in
hippocampus of baso-lateral amygdala (BLA) electrical kindled
epilepsy rat. J Mol Neurosci. 38:201–206. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhang B and Wong M:
Pentylenetetrazole-induced seizures cause acute, but not chronic,
mTOR pathway activation in rat. Epilepsia. 53:506–511. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Jansen LA, Mirzaa GM, Ishak GE, O'Roak BJ,
Hiatt JB, Roden WH, Gunter SA, Christian SL, Collins S, Adams C, et
al: PI3K/AKT pathway mutations cause a spectrum of brain
malformations from megalencephaly to focal cortical dysplasia.
Brain. 138:1613–1628. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Avet-Rochex A, Carvajal N, Christoforou
CP, Yeung K, Maierbrugger KT, Hobbs C, Lalli G, Cagin U, Plachot C,
McNeill H, et al: Unkempt is negatively regulated by mTOR and
uncouples neuronal differentiation from growth control. PLoS Genet.
10:e10046242014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ye M, Bi YF, Ding L, Zhu WW and Gao W:
Saikosaponin a functions as anti-epileptic effect in
pentylenetetrazol induced rats through inhibiting mTOR signaling
pathway. Biomed Pharmacother. 81:281–287. 2016. View Article : Google Scholar : PubMed/NCBI
|
